TE1.STU Bio-Techne Corp
- Market cap
- -
- P/E
- 65.1x
- P/B
- 5.41x
- ROE
- 8.6%
- Dividend yield
- 0.57%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is TE1.STU undervalued?
Graham numberThe Graham number of Bio-Techne Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Bio-Techne Corp fundamental analysis
No fundamental analysis for Bio-Techne Corp yet.
Bio-Techne Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
Bio-Techne Corp financial statements
Bio-Techne Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 714M | 739M | 931M | 1.11B | 1.14B | 1.16B | 1.22B | 1.22B |
| Gross Profit | 473M | 483M | 633M | 756M | 770M | 770M | 790M | 799M |
| Operating Income | 147M | 149M | 243M | 296M | 291M | 246M | 243M | 273M |
| EBITDA | - | 157M | 237M | 398M | 457M | 313M | 217M | 348M |
| Net Income | 96.1M | 229M | 140M | 272M | 285M | 168M | 73.4M | 182M |
| EPS | 0.63 | 1.49 | 0.90 | 1.74 | 1.81 | 1.06 | 0.47 | 1.17 |
| Balance Sheet | ||||||||
| Total Assets | 1.88B | 2.03B | 2.26B | 2.29B | 2.64B | 2.70B | 2.56B | 2.59B |
| Total Liabilities | 719M | 646M | 692M | 594M | 672M | 635M | 639M | 479M |
| Shareholders' Equity | 1.17B | 1.38B | 1.56B | 1.70B | 1.97B | 2.07B | 1.92B | 2.11B |
| Cash & Short-term Investments | 101M | 147M | 199M | 173M | 181M | 152M | 162M | 265M |
| Cash Flow | ||||||||
| Operating Cash Flow | 182M | 205M | 352M | 325M | 254M | 299M | 288M | 292M |
| Capital Expenditure | 25.4M | 51.7M | 44.3M | 44.9M | 38.2M | 62.9M | 31.0M | 28.9M |
| Free Cash Flow | 156M | 153M | 308M | 280M | 216M | 236M | 257M | 263M |
| Ratios | ||||||||
| ROE | 8.2% | 16.6% | 9.0% | 16.0% | 14.5% | 8.1% | 3.8% | 8.6% |
| ROA | 5.1% | 11.3% | 6.2% | 11.9% | 10.8% | 6.2% | 2.9% | 7.0% |
| Net Profit Margin | 13.5% | 31.0% | 15.1% | 24.6% | 25.1% | 14.5% | 6.0% | 15.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Bio-Techne Corp dividends
- Dividend yield
- 0.57%
- Forward dividend
- -
- Payout ratio
- 27.4%
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | USD 49.9M | 0.32 | 27.4% |
| 2025 | USD 50.4M | 0.33 | 68.7% |
| 2024 | USD 50.4M | 0.32 | 30.0% |
| 2023 | USD 50.3M | 0.32 | 17.6% |
| 2022 | USD 50.2M | 0.32 | 18.4% |
| 2021 | USD 49.6M | 0.32 | 35.3% |
| 2020 | USD 48.9M | 0.32 | 21.3% |
| 2019 | USD 48.4M | 0.32 | 50.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 4:1 on Nov 30, 2022.
Who owns Bio-Techne Corp
Ownership data of Bio-Techne Corp is not available yet.
Bio-Techne Corp company profile
- Company name
- Bio-Techne Corp
- Ticker
- TE1.STU
- Exchange
- Stuttgart Exchange
- Sector
- -
- Industry
- -
- Fiscal year end
- June
- Address
- Website
- -